Literature DB >> 19225551

Culture-independent identification of gut bacteria correlated with the onset of diabetes in a rat model.

Luiz F W Roesch1, Graciela L Lorca, George Casella, Adriana Giongo, Andres Naranjo, Arianna M Pionzio, Nan Li, Volker Mai, Clive H Wasserfall, Desmond Schatz, Mark A Atkinson, Josef Neu, Eric W Triplett.   

Abstract

Bacteria associated with the onset of type 1 diabetes in a rat model system were identified. In two experiments, stool samples were collected at three time points after birth from bio-breeding diabetes-prone (BB-DP) and bio-breeding diabetes-resistant (BB-DR) rats. DNA was isolated from these samples and the 16S rRNA gene was amplified using universal primer sets. In the first experiment, bands specific to BB-DP and BB-DR genotypes were identified by automated ribosomal intergenic spacer analysis at the time of diabetes onset in BB-DP. Lactobacillus and Bacteroides strains were identified in the BB-DR- and BB-DP-specific bands, respectively. Sanger sequencing showed that the BB-DP and BB-DR bacterial communities differed significantly but too few reads were available to identify significant differences at the genus or species levels. A second experiment confirmed these results using higher throughput pyrosequencing and quantitative PCR of 16S rRNA with more rats per genotype. An average of 4541 and 3381 16S rRNA bacterial reads were obtained from each of the 10 BB-DR and 10 BB-DP samples collected at time of diabetes onset. Nine genera were more abundant in BB-DP whereas another nine genera were more abundant in BB-DR. Thirteen and eleven species were more abundant in BB-DP and BB-DR, respectively. An average of 23% and 10% of all reads could be classified at the genus and species levels, respectively. Quantitative PCR verified the higher abundance of Lactobacillus and Bifidobacterium in the BB-DR samples. Whether these changes are caused by diabetes or are involved in the development of the disease is unknown.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19225551      PMCID: PMC2972309          DOI: 10.1038/ismej.2009.5

Source DB:  PubMed          Journal:  ISME J        ISSN: 1751-7362            Impact factor:   10.302


  52 in total

1.  Diabetes prone BB rats are severely deficient in natural killer T cells.

Authors:  N N Iwakoshi; D L Greiner; A A Rossini; J P Mordes
Journal:  Autoimmunity       Date:  1999       Impact factor: 2.815

Review 2.  Gapped BLAST and PSI-BLAST: a new generation of protein database search programs.

Authors:  S F Altschul; T L Madden; A A Schäffer; J Zhang; Z Zhang; W Miller; D J Lipman
Journal:  Nucleic Acids Res       Date:  1997-09-01       Impact factor: 16.971

3.  The human Lactobacillus acidophilus strain LA1 secretes a nonbacteriocin antibacterial substance(s) active in vitro and in vivo.

Authors:  M F Bernet-Camard; V Liévin; D Brassart; J R Neeser; A L Servin; S Hudault
Journal:  Appl Environ Microbiol       Date:  1997-07       Impact factor: 4.792

4.  Prevention of diabetes in the BB rat by early immunotherapy using Freund's adjuvant.

Authors:  M W Sadelain; H Y Qin; W Sumoski; N Parfrey; B Singh; A Rabinovitch
Journal:  J Autoimmun       Date:  1990-12       Impact factor: 7.094

5.  Prevention of insulitis and diabetes onset by treatment with complete Freund's adjuvant in NOD mice.

Authors:  M F McInerney; S B Pek; D W Thomas
Journal:  Diabetes       Date:  1991-06       Impact factor: 9.461

6.  Prevention of type I diabetes in NOD mice by adjuvant immunotherapy.

Authors:  M W Sadelain; H Y Qin; J Lauzon; B Singh
Journal:  Diabetes       Date:  1990-05       Impact factor: 9.461

7.  Antimicrobial substance from a human Lactobacillus strain.

Authors:  M Silva; N V Jacobus; C Deneke; S L Gorbach
Journal:  Antimicrob Agents Chemother       Date:  1987-08       Impact factor: 5.191

8.  Influence of environmental viral agents on frequency and tempo of diabetes mellitus in BB/Wor rats.

Authors:  A A Like; D L Guberski; L Butler
Journal:  Diabetes       Date:  1991-02       Impact factor: 9.461

Review 9.  Bacteriocins of gram-positive bacteria.

Authors:  R W Jack; J R Tagg; B Ray
Journal:  Microbiol Rev       Date:  1995-06

10.  Genetic control of diabetes and insulitis in the nonobese diabetic (NOD) mouse.

Authors:  L S Wicker; B J Miller; L Z Coker; S E McNally; S Scott; Y Mullen; M C Appel
Journal:  J Exp Med       Date:  1987-06-01       Impact factor: 14.307

View more
  94 in total

1.  Metagenomics and personalized medicine.

Authors:  Herbert W Virgin; John A Todd
Journal:  Cell       Date:  2011-09-30       Impact factor: 41.582

Review 2.  Role of the gut microbiota in defining human health.

Authors:  Kei E Fujimura; Nicole A Slusher; Michael D Cabana; Susan V Lynch
Journal:  Expert Rev Anti Infect Ther       Date:  2010-04       Impact factor: 5.091

3.  Prolonged antibiotic treatment induces a diabetogenic intestinal microbiome that accelerates diabetes in NOD mice.

Authors:  Kirsty Brown; Artem Godovannyi; Caixia Ma; YiQun Zhang; Zahra Ahmadi-Vand; Chaunbin Dai; Monika A Gorzelak; YeeKwan Chan; Justin M Chan; Arion Lochner; Jan P Dutz; Bruce A Vallance; Deanna L Gibson
Journal:  ISME J       Date:  2015-08-14       Impact factor: 10.302

4.  Shaping the (auto)immune response in the gut: the role of intestinal immune regulation in the prevention of type 1 diabetes.

Authors:  Chiara Sorini; Marika Falcone
Journal:  Am J Clin Exp Immunol       Date:  2013-06-15

Review 5.  Molecular detection, quantification, and diversity evaluation of microalgae.

Authors:  Vinitha Ebenezer; Linda K Medlin; Jang-Seu Ki
Journal:  Mar Biotechnol (NY)       Date:  2011-12-28       Impact factor: 3.619

6.  Gut microbial markers are associated with diabetes onset, regulatory imbalance, and IFN-γ level in NOD mice.

Authors:  Ł Krych; D S Nielsen; A K Hansen; C H F Hansen
Journal:  Gut Microbes       Date:  2015-02-03

Review 7.  Antibiotics, gut microbiota, environment in early life and type 1 diabetes.

Authors:  Youjia Hu; F Susan Wong; Li Wen
Journal:  Pharmacol Res       Date:  2017-02-07       Impact factor: 7.658

Review 8.  The crosstalk of gut microbiota and chronic kidney disease: role of inflammation, proteinuria, hypertension, and diabetes mellitus.

Authors:  Mehmet Kanbay; Emine M Onal; Baris Afsar; Tuncay Dagel; Aslihan Yerlikaya; Adrian Covic; Nosratola D Vaziri
Journal:  Int Urol Nephrol       Date:  2018-05-04       Impact factor: 2.370

9.  Lactobacillus johnsonii N6.2 mitigates the development of type 1 diabetes in BB-DP rats.

Authors:  Ricardo Valladares; Dhyana Sankar; Nan Li; Emily Williams; Kin-Kwan Lai; Asmaa Sayed Abdelgeliel; Claudio F Gonzalez; Clive H Wasserfall; Joseph Larkin; Desmond Schatz; Mark A Atkinson; Eric W Triplett; Josef Neu; Graciela L Lorca
Journal:  PLoS One       Date:  2010-05-06       Impact factor: 3.240

10.  A Strong Impact of Genetic Background on Gut Microflora in Mice.

Authors:  R Steven Esworthy; David D Smith; Fong-Fong Chu
Journal:  Int J Inflam       Date:  2010-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.